Back to Search
Start Over
Outlook on the Worldwide Biosimilars Market to 2025 - Featuring Sandoz, Pfizer, Eli Lilly & Teva Pharmaceutical Among Others - ResearchAndMarkets.com
- Source :
- Business Wire. April 2, 2020
- Publication Year :
- 2020
-
Abstract
- DUBLIN -- The 'Biosimilars Market by Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), Manufacturing (In-house, Contract) & Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease), Region - Global Forecast [...]
- Subjects :
- Contract manufacturing -- Forecasts and trends
Chronic diseases -- Forecasts and trends
Somatotropin -- Forecasts and trends
Biological response modifiers -- Forecasts and trends
Monoclonal antibodies -- Forecasts and trends
Interferon -- Forecasts and trends
Etanercept
Glucagon
Erythropoietin
Enoxaparin
Infliximab
Hormones
Follitropin
Insulin
Granulocyte colony-stimulating factor
Rituximab
Follicle-stimulating hormone
Diseases
Antibodies
Glycoproteins
Calcitonin
Production management
Market trend/market analysis
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.619215761